Potassium Phosphate Drug Product Recalled for Sterility Assurance Defect
Central Admixture Pharmacy Services recalled 2,146 bags of potassium phosphate with sodium chloride solution nationwide because FDA inspection raised concerns about whether the sterile products met required sterility standards.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile drug product where the manufacturer's sterility assurance was questioned by FDA inspection. No illnesses or injuries have been reported. The hazard is theoretical but applies to a high-risk product category where contamination could result in serious harm.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 2,146 bags of potassium phosphate 30 mmole in 0.9% sodium chloride, 500 mL per bag (NDC 71285-7016-1), distributed nationwide. The recall was initiated after an FDA inspection questioned whether these sterile products met required sterility standards.
The affected lots include: 37-883219 (Exp 04/30/2023), 37-885926 (Exp 05/10/2023), 37-887382 (Exp 05/16/2023), 37-889455 (Exp 05/24/2023), 37-890060 (Exp 05/28/2023), 37-893444 (Exp 06/11/2023), and 37-894987 (Exp 06/15/2023).
These prescription-only products were distributed nationwide. Healthcare providers and patients who have received or have in their possession any of the recalled lots should contact Central Admixture Pharmacy Services or the FDA for instructions.
The recalled product
- Product
- potassium phosphate 30 mmole added to 0.9% sodium chloride 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7016-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug
- Hazard
- lack-of-sterility
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot # 37-883219
- Exp 04/30/2023
- 37-885926
- Exp 05/10/2023
- 37-887382
- Exp 05/16/2023
- 37-889455
- Exp 05/24/2023
- 37-890060
- Exp 05/28/2023
- 37-893444
- Exp 06/11/2023
- 37-894987
- Exp 06/15/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27